US Patent Issued to GENEQUANTUM HEALTHCARE (SUZHOU) on Dec. 2 for "Antibody-immune agonist conjugate and applications thereof" (Chinese Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,485,299, issued on Dec. 2, was assigned to GENEQUANTUM HEALTHCARE (SUZHOU) Co. LTD. (Suzhou, China).

"Antibody-immune agonist conjugate and applications thereof" was invented by Paul H. Song (Suzhou, China), Gang Qin (Suzhou, China) and Chong Liu (Suzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a linking unit molecule for targeting molecule-drug conjugate, and the corresponding conjugate, the preparation and use thereof, and in particular relates to an antibody-immune agonist conjugate (AIAC) as a novel type of cancer therapy."

The patent was filed on Aug. 7, 2023, under Application No. 18/366,028.

*For fu...